voriconazole for injection powder for solution
pharmaris canada inc - voriconazole - powder for solution - 200mg - voriconazole 200mg - azoles
voriconazole for injection powder for solution
jamp pharma corporation - voriconazole - powder for solution - 200mg - voriconazole 200mg - azoles
voriconazole for injection powder
auro pharma inc - voriconazole - powder - 200mg - voriconazole 200mg - azoles
voriconazole for injection powder for solution
fresenius kabi canada ltd - voriconazole - powder for solution - 200mg - voriconazole 200mg - azoles
jamp itraconazole oral solution 10mgml
goldplus universal pte ltd - itraconazole - solution - itraconazole 10 mg/ml
jamp voriconazole tablet
jamp pharma corporation - voriconazole - tablet - 50mg - voriconazole 50mg
jamp voriconazole tablet
jamp pharma corporation - voriconazole - tablet - 200mg - voriconazole 200mg
vfend
pfizer new zealand limited - voriconazole 200mg; ; - film coated tablet - 200 mg - active: voriconazole 200mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate opadry white oy-ls-28914 povidone pregelatinised maize starch purified water - vfend is indicated for treatment of the following fungal infections: · invasive aspergillosis. · serious candida sp. infections (including c. krusei), including oesophageal and systemic candida sp. infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). · serious fungal infections caused by scedosporium spp. and fusarium spp. · other serious fungal infections, in patients intolerant of, or refractory to, other therapy.
vfend
pfizer new zealand limited - voriconazole 50mg; ; - film coated tablet - 50 mg - active: voriconazole 50mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate opadry white oy-ls-28914 povidone pregelatinised maize starch purified water - vfend is indicated for treatment of the following fungal infections: · invasive aspergillosis. · serious candida sp. infections (including c. krusei), including oesophageal and systemic candida sp. infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). · serious fungal infections caused by scedosporium spp. and fusarium spp. · other serious fungal infections, in patients intolerant of, or refractory to, other therapy.
vfend
pfizer new zealand limited - voriconazole 200mg; ; - powder for injection - 200 mg - active: voriconazole 200mg excipient: sulfobutyl betadex sodium water for injection - vfend is indicated for treatment of the following fungal infections: · invasive aspergillosis. · serious candida sp. infections (including c. krusei), including oesophageal and systemic candida sp. infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). · serious fungal infections caused by scedosporium spp. and fusarium spp. · other serious fungal infections, in patients intolerant of, or refractory to, other therapy.